ATOPIC DERMATITIS / ECZEMA
Clinical trials for ATOPIC DERMATITIS / ECZEMA explained in plain language.
Never miss a new study
Get alerted when new ATOPIC DERMATITIS / ECZEMA trials appear
Sign up with your email to follow new studies for ATOPIC DERMATITIS / ECZEMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could less medicine keep eczema under control? trial tests spacing out injections
Disease control Recruiting nowThis study is testing whether adults with atopic eczema (atopic dermatitis) that is already well-controlled can safely take their dupilumab medication less often. Researchers will randomly assign 216 participants to receive their standard injection every 2 weeks, or to try extend…
Matched conditions: ATOPIC DERMATITIS / ECZEMA
Phase: PHASE4 • Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
New pill tested to tame severe eczema itch and rash
Disease control Recruiting nowThis study is testing a new oral medication called soquelitinib for adults with moderate to severe eczema (atopic dermatitis). About 200 participants will take either the drug or a placebo pill daily for 12 weeks to see if it safely reduces skin inflammation and itching. Doctors …
Matched conditions: ATOPIC DERMATITIS / ECZEMA
Phase: PHASE2 • Sponsor: Corvus Pharmaceuticals, Inc. • Aim: Disease control
Last updated Mar 31, 2026 12:10 UTC
-
New drug trial offers hope for Tough-to-Treat eczema
Disease control Recruiting nowThis study is testing a new drug called IMG-007 to see if it can reduce the severity of eczema and is safe for adults with moderate-to-severe cases. It will compare different doses of the drug against a placebo (an inactive substance) in about 220 people over 52 weeks. The goal i…
Matched conditions: ATOPIC DERMATITIS / ECZEMA
Phase: PHASE2 • Sponsor: Inmagene LLC • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC